Cargando…

Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()

Analysis of human monoclonal antibodies (mAbs) developed from influenza infected donors have enormously contributed to the identification of neutralization sensitive epitopes of influenza virus. The HA protein is a crucial target of neutralizing antibodies and at monoclonal level only Abs binding to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Latika, Khanna, Madhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128965/
https://www.ncbi.nlm.nih.gov/pubmed/32288920
http://dx.doi.org/10.1016/j.provac.2015.05.009
_version_ 1783516682113777664
author Saxena, Latika
Khanna, Madhu
author_facet Saxena, Latika
Khanna, Madhu
author_sort Saxena, Latika
collection PubMed
description Analysis of human monoclonal antibodies (mAbs) developed from influenza infected donors have enormously contributed to the identification of neutralization sensitive epitopes of influenza virus. The HA protein is a crucial target of neutralizing antibodies and at monoclonal level only Abs binding to HA have been able to neutralize the virus. In this study, eight A (H1N1)pdm 2009 seropositive patients within the age range of 20-50 years (median = 36 years) were recruited. Two anti-HA mAbs secreting stable clones, 2D8 and 2F12 were established under optimized conditions from the peripheral blood mononuclear cells (PBMCs) of the volunteers. These antibodies efficiently neutralized the homologous laboratory isolated strain of the pandemic virus as well as the reference strain. Our study suggests that the anti-HA antibodies derived from infected Indian patients display neutralization potential against the A(H1N1)pdm 2009 virus. This is the first ever study of generation of mAbs against the pandemic influenza virus involving the immune repertoire if Indian patients. Molecular characterization of the target regions will help in identifying potential immunogens in the Indian pandemic isolates and confer protective immunity against this virus.
format Online
Article
Text
id pubmed-7128965
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71289652020-04-08 Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors() Saxena, Latika Khanna, Madhu Procedia Vaccinol Article Analysis of human monoclonal antibodies (mAbs) developed from influenza infected donors have enormously contributed to the identification of neutralization sensitive epitopes of influenza virus. The HA protein is a crucial target of neutralizing antibodies and at monoclonal level only Abs binding to HA have been able to neutralize the virus. In this study, eight A (H1N1)pdm 2009 seropositive patients within the age range of 20-50 years (median = 36 years) were recruited. Two anti-HA mAbs secreting stable clones, 2D8 and 2F12 were established under optimized conditions from the peripheral blood mononuclear cells (PBMCs) of the volunteers. These antibodies efficiently neutralized the homologous laboratory isolated strain of the pandemic virus as well as the reference strain. Our study suggests that the anti-HA antibodies derived from infected Indian patients display neutralization potential against the A(H1N1)pdm 2009 virus. This is the first ever study of generation of mAbs against the pandemic influenza virus involving the immune repertoire if Indian patients. Molecular characterization of the target regions will help in identifying potential immunogens in the Indian pandemic isolates and confer protective immunity against this virus. Published by Elsevier B.V. 2015 2015-05-22 /pmc/articles/PMC7128965/ /pubmed/32288920 http://dx.doi.org/10.1016/j.provac.2015.05.009 Text en Copyright © 2015 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Saxena, Latika
Khanna, Madhu
Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
title Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
title_full Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
title_fullStr Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
title_full_unstemmed Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
title_short Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
title_sort production and characterization of human monoclonal antibodies from the cells of a(h1n1)pdm2009 influenza virus infected indian donors()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128965/
https://www.ncbi.nlm.nih.gov/pubmed/32288920
http://dx.doi.org/10.1016/j.provac.2015.05.009
work_keys_str_mv AT saxenalatika productionandcharacterizationofhumanmonoclonalantibodiesfromthecellsofah1n1pdm2009influenzavirusinfectedindiandonors
AT khannamadhu productionandcharacterizationofhumanmonoclonalantibodiesfromthecellsofah1n1pdm2009influenzavirusinfectedindiandonors